Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
30 03 2021
Historique:
received: 13 02 2020
accepted: 26 02 2021
entrez: 31 3 2021
pubmed: 1 4 2021
medline: 20 4 2021
Statut: epublish

Résumé

Periods of fasting and refeeding may reduce cardiometabolic risk elevated by Western diet. Here we show in the substudy of NCT02099968, investigating the clinical parameters, the immunome and gut microbiome exploratory endpoints, that in hypertensive metabolic syndrome patients, a 5-day fast followed by a modified Dietary Approach to Stop Hypertension diet reduces systolic blood pressure, need for antihypertensive medications, body-mass index at three months post intervention compared to a modified Dietary Approach to Stop Hypertension diet alone. Fasting alters the gut microbiome, impacting bacterial taxa and gene modules associated with short-chain fatty acid production. Cross-system analyses reveal a positive correlation of circulating mucosa-associated invariant T cells, non-classical monocytes and CD4

Identifiants

pubmed: 33785752
doi: 10.1038/s41467-021-22097-0
pii: 10.1038/s41467-021-22097-0
pmc: PMC8010079
doi:

Banques de données

ClinicalTrials.gov
['NCT02099968']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1970

Références

Obes Facts. 2008;1(6):319-24
pubmed: 20054195
Nature. 2015 Dec 10;528(7581):262-266
pubmed: 26633628
Bioinformatics. 2014 Oct;30(19):2811-2
pubmed: 24930139
Cardiovasc Res. 2018 Sep 1;114(11):1547-1563
pubmed: 29800237
Diabetes. 2012 Feb;61(2):401-8
pubmed: 22228716
J Am Heart Assoc. 2019 Sep 3;8(17):e012401
pubmed: 31451009
Bioinformatics. 2017 Aug 15;33(16):2594-2595
pubmed: 28398468
Lancet. 1991 Oct 12;338(8772):899-902
pubmed: 1681264
Cell Host Microbe. 2016 May 11;19(5):731-43
pubmed: 27173935
Science. 2018 Nov 16;362(6416):770-775
pubmed: 30442801
JAMA. 2003 Apr 23-30;289(16):2083-93
pubmed: 12709466
Nature. 2008 May 15;453(7193):396-400
pubmed: 18425110
Circulation. 2018 Oct 23;138(17):e484-e594
pubmed: 30354654
Nucleic Acids Res. 2014 Jan;42(Database issue):D643-8
pubmed: 24293649
J Am Coll Cardiol. 1996 Nov 1;28(5):1103-8
pubmed: 8890801
Nat Methods. 2013 Sep;10(9):881-4
pubmed: 23892899
Microbiome. 2018 Apr 19;6(1):72
pubmed: 29669589
Nat Commun. 2019 Mar 4;10(1):1014
pubmed: 30833550
Lancet. 2019 May 11;393(10184):1958-1972
pubmed: 30954305
PLoS One. 2012;7(2):e30126
pubmed: 22319561
Lancet. 1994 Jun 11;343(8911):1454-9
pubmed: 7911176
Metabolism. 1991 Sep;40(9):908-17
pubmed: 1895955
Microbiome. 2017 Feb 1;5(1):14
pubmed: 28143587
Science. 2007 Nov 30;318(5855):1449-52
pubmed: 17947550
Circ Res. 2016 Apr 15;118(8):1233-43
pubmed: 26988069
Nat Methods. 2013 Oct;10(10):996-8
pubmed: 23955772
Benef Microbes. 2020 May 11;11(3):227-233
pubmed: 32073296
Microbes Environ. 2014;29(4):427-30
pubmed: 25283478
BMC Med Res Methodol. 2004 Nov 09;4:26
pubmed: 15535880
Blood Press Monit. 2005 Oct;10(5):239-42
pubmed: 16205441
Cell. 2014 Nov 6;159(4):789-99
pubmed: 25417156
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4516-22
pubmed: 20534432
Nat Rev Immunol. 2019 May;19(5):267-268
pubmed: 30911129
J Clin Invest. 2014 Oct;124(10):4642-56
pubmed: 25244096
PLoS One. 2019 Jul 18;14(7):e0219489
pubmed: 31318902
Bioinformatics. 2011 Nov 1;27(21):2957-63
pubmed: 21903629
N Engl J Med. 1997 Apr 17;336(16):1117-24
pubmed: 9099655
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361
pubmed: 27899662
Nature. 2009 Jan 22;457(7228):480-4
pubmed: 19043404
Nutr J. 2018 Jul 30;17(1):72
pubmed: 30060746
Nature. 2012 Oct 4;490(7418):55-60
pubmed: 23023125
Cell Host Microbe. 2017 Jun 14;21(6):682-694.e5
pubmed: 28618267
Circulation. 2019 Mar 12;139(11):1407-1421
pubmed: 30586752
Circulation. 2002 Jan 22;105(3):310-5
pubmed: 11804985
Nat Rev Immunol. 2019 Aug;19(8):517-532
pubmed: 30992524
Nucleic Acids Res. 2016 Jan 4;44(D1):D457-62
pubmed: 26476454
Environ Microbiol. 2009 Jul;11(7):1736-51
pubmed: 19508560
BMJ Open. 2018 Jul 28;8(7):e021682
pubmed: 30056386
Front Immunol. 2018 Apr 27;9:908
pubmed: 29755475
JAMA. 2004 Sep 22;292(12):1440-6
pubmed: 15383514
PeerJ. 2020 Jan 14;8:e8317
pubmed: 31976177
Cytometry A. 2015 Jul;87(7):636-45
pubmed: 25573116
Front Cell Infect Microbiol. 2017 Aug 24;7:381
pubmed: 28884091
J Clin Invest. 2015 Apr;125(4):1752-62
pubmed: 25751065
Nat Commun. 2020 Feb 18;11(1):855
pubmed: 32071312
Science. 2006 Mar 3;311(5765):1283-7
pubmed: 16513982
Gut. 2019 Jan;68(1):83-93
pubmed: 29097438
Nat Biotechnol. 2014 Aug;32(8):834-41
pubmed: 24997786
J Clin Biochem Nutr. 2016 Jul;59(1):65-70
pubmed: 27499582
Exp Clin Endocrinol Diabetes. 2017 Oct;125(9):618-624
pubmed: 28407662
PLoS One. 2015 Nov 02;10(11):e0141590
pubmed: 26523925
Curr Oncol. 2012 Oct;19(5):e343-52
pubmed: 23144582
FASEB J. 2018 Apr 27;:fj201800052RR
pubmed: 29957059
Microbiome. 2014 Sep 30;2(1):30
pubmed: 27367037
J Nutr Sci. 2019 Nov 12;8:e36
pubmed: 31798864
Nat Commun. 2017 Oct 10;8(1):845
pubmed: 29018189
Anaerobe. 2019 Feb;55:67-77
pubmed: 30396006
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Nat Microbiol. 2016 Jun 13;1(8):16088
pubmed: 27573110
PLoS One. 2016 Feb 26;11(2):e0149564
pubmed: 26919743
N Engl J Med. 2016 Dec 15;375(24):2369-2379
pubmed: 27974040

Auteurs

András Maifeld (A)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Hendrik Bartolomaeus (H)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Ulrike Löber (U)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Ellen G Avery (EG)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Department of Biology, Chemistry, and Pharmacy, Freie Universität Berlin, Berlin, Germany.

Nico Steckhan (N)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Department of Internal and Integrative Medicine, Immanuel Krankenhaus Berlin, Berlin, Germany.

Lajos Markó (L)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.

Nicola Wilck (N)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Nephrology and Internal Intensive Care Medicine, Berlin, Germany.

Ibrahim Hamad (I)

VIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research (IRC), UHasselt, Campus Diepenbeek, Hasselt, Belgium.
Department of Immunology, Biomedical Research Institute, UHasselt, Campus Diepenbeek, Hasselt, Belgium.

Urša Šušnjar (U)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.

Anja Mähler (A)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.

Christoph Hohmann (C)

Department of Internal and Integrative Medicine, Immanuel Krankenhaus Berlin, Berlin, Germany.

Chia-Yu Chen (CY)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Holger Cramer (H)

Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.

Gustav Dobos (G)

Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.

Till Robin Lesker (TR)

Department of Microbial Immune Regulation, Helmholtz Centre for Infection Research, Braunschweig, Germany.

Till Strowig (T)

Department of Microbial Immune Regulation, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Hannover Medical School, Hannover, Germany.

Ralf Dechend (R)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Department of Cardiology and Nephrology, HELIOS-Klinikum, Berlin, Germany.

Danilo Bzdok (D)

Department of Biomedical Engineering, McConnell Brain Imaging Centre, Montreal Neurological Institute, Faculty of Medicine, McGill University, Montreal, Canada.
Mila - Quebec Artificial Intelligence Institute, Montreal, Canada.
Parietal Team, Institut National de Recherche en Informatique et en Automatique (INRIA), Neurospin, Commissariat à l'Energie Atomique (CEA) Saclay, Gif-sur-Yvette, France.

Markus Kleinewietfeld (M)

VIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research (IRC), UHasselt, Campus Diepenbeek, Hasselt, Belgium.
Department of Immunology, Biomedical Research Institute, UHasselt, Campus Diepenbeek, Hasselt, Belgium.

Andreas Michalsen (A)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. andreas.michalsen@charite.de.
Department of Internal and Integrative Medicine, Immanuel Krankenhaus Berlin, Berlin, Germany. andreas.michalsen@charite.de.

Dominik N Müller (DN)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany. dominik.mueller@mdc-berlin.de.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. dominik.mueller@mdc-berlin.de.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany. dominik.mueller@mdc-berlin.de.
Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany. dominik.mueller@mdc-berlin.de.

Sofia K Forslund (SK)

Experimental and Clinical Research Center, a joint cooperation of Max Delbruck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany. sofia.forslund@mdc-berlin.de.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. sofia.forslund@mdc-berlin.de.
DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany. sofia.forslund@mdc-berlin.de.
Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany. sofia.forslund@mdc-berlin.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH